Strategies for antiviral therapy in AIDS

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Nature

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/325773A0PMID 2434858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AIDS, modern concepts and therapeutic challenges

  1987cited by this paper
• Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine.

  1987cited by this paper
• Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity.

  1986cited by this paper
• Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

  1986cited by this paper
• HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

  1986cited by this paper
• Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.

  1986cited by this paper
• Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.

  1986cited by this paper
• The role of mononuclear phagocytes in HTLV-III/LAV infection.

  1986cited by this paper
• Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

  1986cited by this paper
• Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

  1986cited by this paper
• Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

  1986cited by this paper
• Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system.

  1986cited by this paper
• Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli

  1986cited by this paper
• Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

  1986cited by this paper
• Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

  1986cited by this paper
• Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.

  1986cited by this paper
• Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III

  1986cited by this paper
• Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.

  1986cited by this paper
• What to call the AIDS virus?

  1986cited by this paper
• A second post-transcriptional trans-activator gene required for HTLV-III replication

  1986cited by this paper
• Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.

  1986cited by this paper
• Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein

  1986cited by this paper
• Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

  1985cited by this paper
• Nucleotide sequence of the AIDS virus, LAV.

  1985cited by this paper
• Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.

  1985cited by this paper
• Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

  1985cited by this paper
• HTLV-III infection in brains of children and adults with AIDS encephalopathy.

  1985cited by this paper
• Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.

  1985cited by this paper
• 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

  1985cited by this paper
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome.

  1985cited by this paper
• Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses

  1985cited by this paper
• Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.

  1985cited by this paper
• Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.

  1985cited by this paper
• Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

  1984cited by this paper
• The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

  1984cited by this paper
• T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV

  1984cited by this paper
• Effects of 2′,3′‐dideoxynucleosides on mammalian cells and viruses

  1984cited by this paper
• Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

  1984cited by this paper
• Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

  1984cited by this paper
• Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes.

  1984cited by this paper
• A pathogenic retrovirus (HTLV-III) linked to AIDS.

  1984cited by this paper
• Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

  1984cited by this paper
• In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid

  1983cited by this paper
• Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

  1983cited by this paper
• Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification.

  1983cited by this paper
• Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus

  1983cited by this paper
• Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

  1981cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus.

  1974cited by this paper
• Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of Rous Sarcoma Virus

  1970cited by this paper
• Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of RNA Tumour Viruses

  1970cited by this paper
• RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

  1970cited by this paper
• Effect of Parathyroid Extract on Cyclic AMP Content of Embryonic Mouse Calvaria

  1970cited by this paper
• Termination of Deoxyribonucleic Acid in Escherichia coli by 2′,3′-Dideoxyadenosine

  1970cited by this paper
• Enzymatic synthesis of deoxyribonucleic acid. XXXIV. Termination of chain growth by a 2',3'-dideoxyribonucleotide.

  1969cited by this paper
• Nucleosides. XI. 2',3'-dideoxycytidine.

  1967cited by this paper
• Polymer Synthesis in Killed Bacteria: Lethality of 2′,3′-Dideoxyadenosine

  1966cited by this paper
• Nucleosides. V. The Monomesylates of 1-(2'-Deoxy-β-D-lyxofuranosyl)thymine1,2

  1964cited by this paper
• The Synthesis of 2′,3′-Dideoxyadenosine from 2′-Deoxyadenosine

  1964cited by this paper

• Rational Design and Multi‐tiered Computational Evaluation of Novel Darunavir Derivatives as HIV‐1 Protease Inhibitors: an Integrated Approach Using QSAR Model, Molecular Docking, MD Simulations, DFT Analysis, and ADME Profiling

  2025cites this paper
• The Role of AZT (Azidothymidine) in the Treatment of HIV and AIDS

  2025cites this paper
• Clinical Value of Patient-Reported Outcomes for People Living with HIV: Mini-Review

  2024cites this paper
• Development of gradient diffusion strips to identify the potentiating effect of antimicrobial compounds against multidrug-resistant Klebsiella pneumoniae strains

  2024cites this paper
• HIV-1 protease inhibitors and mechanisms of HIV-1's resistance.

  2024cites this paper
• Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors.

  2023cites this paper
• Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to slow aging.

  2023cites this paper
• HIV nucleoside reverse transcriptase inhibitors.

  2022cites this paper
• A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants.

  2022cites this paper
• Protection of Retinal Function by Nucleoside Reverse Transcriptase Inhibitors Following Retinal Ischemia/Reperfusion Injury

  2021cites this paper
• Design and evaluation of novel piperidine HIV-1 protease inhibitors with potency against DRV-resistant variants.

  2021cites this paper
• Acanthaster planci Inhibits PCSK9 and Lowers Cholesterol Levels in Rats

  2021cites this paper
• POTENTIAL MARINE-DERIVED FUNGI ISOLATED FROM SPONGE IN PRODUCE NEW AND BENEFICIAL COMPOUNDS

  2020cites this paper
• Novel HIV-1 Protease Inhibitors with Morpholine as the P2 Ligand to Enhance Activity against DRV-Resistant Variants.

  2020cites this paper
• A SYSTEMATIC REVIEW ON METAL COMPLEXES OF SOME MEDICINAL COMPOUNDS

  2020cites this paper
• Design and biological evaluation of novel HIV-1 protease inhibitors with isopropanol as P1' ligand to enhance binding with S1' subsite.

  2020cites this paper
• Activity of Tigecycline or Colistin in Combination with Zidovudine against Escherichia coli Harboring tet(X) and mcr-1

  2020cites this paper
• Identification of Aristolactam Derivatives That Act as Inhibitors of Human Immunodeficiency Virus Type 1 Infection and Replication by Targeting Tat-Mediated Viral Transcription

  2020cites this paper
• Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals.

  2019cites this paper
• Molecular Pathology of HTLV-1

  2019cites this paper
• Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication

  2019cites this paper
• How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy

  2018cites this paper
• RME-based pharmacology: The inhibition of viral entry as therapeutic perspective in viral diseases including AIDS. Hypothesis updated and enlarged

  2018influential citation
• Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies.

  2015cites this paper
• 4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus

  2015cites this paper
• Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells

  2015cites this paper
• New organochalcogen multitarget drug: synthesis and antioxidant and antitumoral activities of chalcogenozidovudine derivatives.

  2015cites this paper
• Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial.

  2015cites this paper
• Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells.

  2014cites this paper
• Research on the Chemical Materials of Inosine Di- and Triphosphate

  2014cites this paper
• Identification and evaluation of inhibitors targeting the HIV-1 integrase-LEDGF/p75 interaction

  2014cites this paper
• Glycal-derived δ-hydroxy α,β-unsaturated aldehydes (Perlin aldehydes): versatile building blocks in organic synthesis.

  2013cites this paper
• Conformation depends on 4D-QSAR analysis using EC–GA method: pharmacophore identification and bioactivity prediction of TIBOs as non-nucleoside reverse transcriptase inhibitors

  2013cites this paper
• HIV AND AIDS

  2013cites this paper
• Development of the First AIDS Drugs: AZT and Other Dideoxynueosides

  2013cites this paper
• Genome-Wide Host Gene Expression Analysis Before and After the Initiation of Highly Active Antiretroviral Therapy And Natural Control of HIV in Therapy Naïve HIV+ Non-Progressors

  2013cites this paper
• Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.

  2012influential citation
• Enhancing Protein Backbone Binding—A Fruitful Concept for Combating Drug‐Resistant HIV†

  2012cites this paper
• Combination Antiretroviral Therapy

  2012cites this paper
• Modeling anti-HIV compounds: the role of analogue-based approaches.

  2012cites this paper
• Zidovudine

  2012cites this paper
• Synthesis, evaluation of anti-HIV-1 and anti-HCV activity of novel 2',3'-dideoxy-2',2'-difluoro-4'-azanucleosides.

  2012cites this paper
• Verstärkung der Bindung an das Proteinrückgrat – ein fruchtbares Konzept gegen die Arzneimittelresistenz von HIV†

  2012cites this paper
• Cofactors in Coronavirus Entry

  2011influential citation
• Characterizing Plasmacytoid Dendritic Cell Activation in the Context of HIV Stimulation

  2011cites this paper
• The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

  2010cites this paper
• Non covalent inclusion of nucleosides and nucleotides in water-soluble molecular clips

  2010cites this paper
• Étude d'inhibiteurs de l'intégrase du VIH-1 par RMN et modélisation moléculaire : Développement et validation d'un outil de criblage virtuel. (HIV-1 integrase inhibitors study by NMR and molecular modeling)

  2010cites this paper
• Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go?

  2010cites this paper
• Chromatographic separation of antiviral/anticancer nucleoside reverse transcriptase inhibitor drugs

  2010cites this paper
• Research Article: Synthesis, Biological Evaluation and Molecular Modeling Studies of N‐aryl‐2‐arylthioacetamides as Non‐nucleoside HIV‐1 Reverse Transcriptase Inhibitors

  2010cites this paper
• CHAPTER 109 – Viral Genomics and Antiviral Drugs

  2009cites this paper
• Current development of Pd(II) complexes as potential antitumor agents.

  2009cites this paper
• Predicting anti-HIV-1 activity of 6-arylbenzonitriles: computational approach using superaugmented eccentric connectivity topochemical indices.

  2008cites this paper
• Possible New Reaction Mechanisms of Dideoxynucleosides as Anti-Aids Drugs

  2008cites this paper
• As the tide turns: the changing HIV/AIDS epidemic and the criminalization of HIV exposure.

  2008cites this paper
• Special features of the nucleophilic substitution of halogen in alkyl and benzyl halides with anions generated from 4-hydroxy-2-mercapto-6-methylpyrimidine

  2008cites this paper
• Development of protease inhibitors and the fight with drug-resistant HIV-1 variants.

  2008cites this paper
• The past, present, and future of AIDS.

  2008cites this paper
• A History of Drug Discovery

  2008cites this paper
• Colorectal Cancer Metastasis Model Mediated Suicide Gene Therapy in a Multifocal − Vector Therapeutic Efficacy of Replication-Competent Retrovirus

  2007cites this paper
• The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.

  2007cites this paper
• HIV and AIDS Therapeutics

  2007cites this paper
• Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model.

  2007cites this paper
• Antiproliferative activity of Pt(II) and Pd(II) phosphine complexes with thymine and thymidine.

  2007cites this paper
• Cell permeation of a Trypanosoma brucei aldolase inhibitor: evaluation of different enzyme-labile phosphate protecting groups.

  2006cites this paper
• The design and synthesis of 9-phenylcyclohepta[d]pyrimidine-2,4-dione derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase.

  2006cites this paper
• New Azt Conjugates as Potent Anti-HIV Agents

  2006cites this paper
• Towards discovering dual functional inhibitors against both wild type and K103N mutant HIV-1 reverse transcriptases: molecular docking and QSAR studies on 4,1-benzoxazepinone analogues

  2006cites this paper
• In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine).

  2005cites this paper
• Potent Anti-R5 Human Immunodeficiency Virus Type 1 Effects of a CCR5 Antagonist, AK602/ONO4128/GW873140, in a Novel Human Peripheral Blood Mononuclear Cell Nonobese Diabetic-SCID, Interleukin-2 Receptor γ-Chain-Knocked-Out AIDS Mouse Model

  2005cites this paper
• Tandem Oxidation Sequence to Prepare Ethyl (E)‐4,5‐Dioxo‐2‐hexadecenoate: A Formal Synthesis of Podoscyphic Acid

  2005cites this paper
• Persistent herpes simplex virus infection and mechanisms of virus drug resistance

  2005cites this paper
• Étude des mécanismes non-conventionnels de traduction chez le virus de l'immunodéficience humaine de type 1 et le virus de l'hépatite C

  2005cites this paper
• Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma.

  2005cites this paper
• From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  2005cites this paper
• Pyrimidine and nucleoside gamma-esters of L-Glu-Sar: synthesis, stability and interaction with hPEPT1.

  2005cites this paper
• Pyrimidine and nucleoside γ-esters of l-Glu-Sar: Synthesis, stability and interaction with hPEPT1

  2005cites this paper
• C-C Bond Formation at C-5 Position of Dimethyluracil Derivatives Using SmI 2

  2004cites this paper
• Highly active antiretroviral therapy and viral response in HIV type 2 infection.

  2004cites this paper
• Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production

  2004cites this paper
• In Vitro and in Vivo Transport and Delivery of Phosphorothioate Oligonucleotides with Cationic Liposomes

  2004cites this paper
• Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors.

  2004cites this paper
• Search for new drugs for the treatment of HIV infections among nucleosides and nucleotides. II

  2004cites this paper
• Zinc-nucleic acid interaction.

  2004cites this paper
• Alkylation of 2‐pyridinones: Synthesis of novel acyclonucleosides

  2004cites this paper
• Replicative retroviral vectors for cancer gene therapy

  2003cites this paper
• 1 – A BRIEF HISTORY OF DRUGS: FROM PLANT EXTRACTS TO DNA TECHNOLOGY

  2003cites this paper
• Asymmetrically Substituted myo-Inositols. XXXIX. The Synthesis of Conjugate of 2',3'-Didehydro-3'-deoxythymidine with Phosphatidylinositol: A New Nucleoside Phospholipid with Potential Anti-HIV Activity

  2003cites this paper
• Correlation of micronuclei-induction with the cell survival in HeLa cells treated with a base analogue, azidothymidine (AZT) before exposure to different doses of gamma-radiation.

  2003cites this paper
• Synthesis, Anti-HIV, and Cytotoxic Activity of New AZT Conjugates of Steroid Acids

  2003cites this paper
• [Study of asymmetrically substituted myo-inositols. XXXIX. The synthesis of conjugate of 2',3'-didehydro-3'-dehydroxythymidine with phosphatidylinositol: a new nucleoside phospholipid with potential anti-HIV activity].

  2003cites this paper
• Synthesis and structure determination of some new N-glycosides of 4,5-disubstituted-1,2,4-triazole-3-thiones

  2002cites this paper
• Recent progress in artificial receptors for phosphate anions in aqueous solution.

  2002cites this paper
• HPLC DETERMINATION OF ACYCLOVIR AND ZIDOVUDINE IN MATERNAL PLASMA, AMNIOTIC FLUID, FETAL, AND PLACENTAL TISSUES USING ULTRA-VIOLET DETECTION

  2002influential citation
• Delivery of Anti-Viral Nucleoside Analogues to the Central Nervous System

  2002cites this paper
• SYNTHESIS AND IN VITRO ANTIBACTERIAL ACTIVITY OF NOVEL 5′-O-ANALOG DERIVATIVES OF ZIDOVUDINE AS POTENTIAL PRODRUGS

  2002cites this paper
• Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.

  2002cites this paper
• CelI Signaling, the Immune Response, the Genetic Basis of Cancer, and Efforts to Pinpoint the Genes for Alzheirner’s Dkase, Cystic Fibrosis, and Manic-Depressive Illness Are Highlighted in 1987 Life-Sciences Research

  2001cites this paper
• Creating Novel Molecular Transport Systems: the Synthesis and Antiviral Activity of Mixed Succinates of Deoxynucleotides and Hydrophobic Molecules

  2001cites this paper